Stanford Scientists Transplant Lab-Grown Human Brain Tissue into Mice

Researchers at Stanford University have achieved a significant milestone in neuroscience by successfully transplanting lab-grown human brain tissue into specially bred mice. This development, detailed in the journal Nature, offers a novel approach to studying brain disorders and their potential treatments.

The study involved creating three-dimensional cultures of human brain tissue, known as cortical organoids, derived from human skin cells. These organoids were then implanted into mice engineered to have a significantly underdeveloped cerebral cortex. According to Stanford Medicine, the transplanted human brain tissue not only survived but also grew and integrated into the host animals' nervous systems, forming functional connections with the mice's brains and spinal cords.

Professor Sergiu Pasca, the senior author of the study, described the resulting animals as "xenocortical" mice. He explained that while these mice retain their native nervous systems, they now possess a larger volume of human cortical tissue that develops and connects within the host. "They are not miniature brains and do not reproduce the full complexity of the human brain, but they allow us to study human neural cell types and developmental processes that would otherwise be extremely difficult to access," Pasca stated.

This innovative research holds promise for understanding a range of neurodevelopmental disorders, including autism, schizophrenia, cerebral palsy, and epilepsy. Scientists can now investigate how genetic factors associated with these conditions affect neural development and circuitry, and explore whether potential therapeutic interventions can mitigate or correct these changes.

"We can begin to ask how disease-associated human genetic changes alter neural development and circuitry and whether potential treatments can prevent or correct those changes," Pasca added.

Alison Singer, president of the Autism Science Foundation, lauded the research as a "critical step" toward precision medicine. She emphasized the ability to create organoid models reflecting an individual's unique genetic makeup to understand brain abnormalities. The study addresses the long-standing challenges in brain research, particularly the ethical and practical difficulties of studying living human brain tissue.

Neuroscientists anticipate that this methodology will significantly enhance the study of neurodevelopmental and pregnancy-related disorders, providing new avenues for testing preventive and corrective interventions.